Asian and older rheumatoid arthritis sufferers 50% less likely to receive targeted treatment, finds study

Asian patients are half as likely to be started on biologic drugs for rheumatoid arthritis as white patients, new research has shown.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup